Jaqueline Corrigan-Curay, who serves as acting head of the FDA’s Center for Drug Evaluation and Research, will depart next ...

Recent shifts within the U.S. FDA reflect an increasingly complex tension between scientific rigor and accelerating political ...

Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...

And more health news stories you need to start your week.

But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...

As the market for AI enabled medical devices grows, experts say there is less transparency around device approvals.

Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research ...

Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been ...

Two major food companies will begin removing artificial dyes from their products, as per the recommendations made by the ...

One of the country's biggest food manufacturers is getting on board with Health Secretary RFK Jr.'s plans to stop the industry from using synthetic dyes. FDA Commissioner Dr. Marty Makary joins "The ...

An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...